These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1691 related items for PubMed ID: 17540211

  • 1. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure and chronic kidney disease.
    Berger AK, Duval S, Manske C, Vazquez G, Barber C, Miller L, Luepker RV.
    Am Heart J; 2007 Jun; 153(6):1064-73. PubMed ID: 17540211
    [Abstract] [Full Text] [Related]

  • 2. National patterns of use and effectiveness of angiotensin-converting enzyme inhibitors in older patients with heart failure and left ventricular systolic dysfunction.
    Masoudi FA, Rathore SS, Wang Y, Havranek EP, Curtis JP, Foody JM, Krumholz HM.
    Circulation; 2004 Aug 10; 110(6):724-31. PubMed ID: 15289383
    [Abstract] [Full Text] [Related]

  • 3. Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure: an observational study of treatment rates and clinical outcome.
    Gotsman I, Rubonivich S, Azaz-Livshits T.
    Isr Med Assoc J; 2008 Mar 10; 10(3):214-8. PubMed ID: 18494235
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study.
    Go AS, Yang J, Ackerson LM, Lepper K, Robbins S, Massie BM, Shlipak MG.
    Circulation; 2006 Jun 13; 113(23):2713-23. PubMed ID: 16754803
    [Abstract] [Full Text] [Related]

  • 6. The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease.
    Ezekowitz J, McAlister FA, Humphries KH, Norris CM, Tonelli M, Ghali WA, Knudtson ML, APPROACH Investigators.
    J Am Coll Cardiol; 2004 Oct 19; 44(8):1587-92. PubMed ID: 15489090
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Does aspirin use adversely influence intermediate-term postdischarge outcomes for hospitalized patients who are treated with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers? Findings from Organized Program to Facilitate Life-Saving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).
    Levy PD, Nandyal D, Welch RD, Sun JL, Pieper K, Ghali JK, Fonarow GC, Gheorghiade M, O'Connor CM.
    Am Heart J; 2010 Feb 19; 159(2):222-230.e2. PubMed ID: 20152220
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Long-term trends of angiotensin-converting enzyme inhibitor and angiotensin-receptor blocker use after heart failure hospitalization in community-dwelling seniors.
    Setoguchi S, Levin R, Winkelmayer WC.
    Int J Cardiol; 2008 Apr 10; 125(2):172-7. PubMed ID: 17997175
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Renal failure is an independent predictor of mortality in hospitalized heart failure patients and is associated with a worse cardiovascular risk profile].
    Grigorian Shamagian L, Varela Román A, Pedreira Pérez M, Gómez Otero I, Virgós Lamela A, González-Juanatey JR.
    Rev Esp Cardiol; 2006 Feb 10; 59(2):99-108. PubMed ID: 16540030
    [Abstract] [Full Text] [Related]

  • 14. Distinct time courses of renal protective action of angiotensin receptor antagonists and ACE inhibitors in chronic renal disease.
    Matsuda H, Hayashi K, Saruta T.
    J Hum Hypertens; 2003 Apr 10; 17(4):271-6. PubMed ID: 12692572
    [Abstract] [Full Text] [Related]

  • 15. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR.
    Clin Ther; 2007 Sep 10; 29(9):1803-24. PubMed ID: 18035185
    [Abstract] [Full Text] [Related]

  • 16. Prognostic benefit of beta-blockers in patients not receiving ACE-Inhibitors.
    Krum H, Haas SJ, Eichhorn E, Ghali J, Gilbert E, Lechat P, Packer M, Roecker E, Verkenne P, Wedel H, Wikstrand J.
    Eur Heart J; 2005 Oct 10; 26(20):2154-8. PubMed ID: 16014644
    [Abstract] [Full Text] [Related]

  • 17. Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation.
    Heinze G, Mitterbauer C, Regele H, Kramar R, Winkelmayer WC, Curhan GC, Oberbauer R.
    J Am Soc Nephrol; 2006 Mar 10; 17(3):889-99. PubMed ID: 16481415
    [Abstract] [Full Text] [Related]

  • 18. Facility variation in utilization of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in patients with diabetes mellitus and chronic kidney disease.
    Tiwari A, Tseng CL, Kern EF, Maney M, Miller DR, Pogach L.
    Am J Manag Care; 2007 Feb 10; 13(2):73-9. PubMed ID: 17286527
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Heart failure: critical patients].
    Fabbri G, Gorini M, Maggioni AP, Oliva F, ANMCO.
    G Ital Cardiol (Rome); 2007 Sep 10; 8(9):568-73. PubMed ID: 17972426
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 85.